GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Feb 2016 05:05 PM
RNS
PhII HIV prevention study results cabotegravir
23 Feb 2016 05:13 PM
RNS
PhII data on 2 drug long-acting injectable for HIV
22 Feb 2016 03:38 PM
RNS
ViiV completes transaction to acquire BMS Assets
18 Feb 2016 02:27 PM
RNS
Director/PDMR Shareholding
16 Feb 2016 05:22 PM
RNS
Director/PDMR Shareholding- Replacement
16 Feb 2016 05:20 PM
RNS
Director/PDMR Shareholding- Replacement
16 Feb 2016 04:16 PM
RNS
Director/PDMR Shareholding
16 Feb 2016 04:13 PM
RNS
Director/PDMR Shareholding
15 Feb 2016 05:58 PM
RNS
Director/PDMR Shareholding
15 Feb 2016 05:55 PM
RNS
Director/PDMR Shareholding
15 Feb 2016 10:55 AM
RNS
Director/PDMR Shareholding
12 Feb 2016 04:21 PM
RNS
Director/PDMR Shareholding
12 Feb 2016 04:20 PM
RNS
Director/PDMR Shareholding
12 Feb 2016 04:16 PM
RNS
Director/PDMR Shareholding
10 Feb 2016 01:00 PM
RNS
Director/PDMR Shareholding
03 Feb 2016 12:00 PM
RNS
Final Results
02 Feb 2016 09:46 AM
RNS
Director/PDMR Shareholding
01 Feb 2016 05:04 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 03:41 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 01:04 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 01:00 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 12:57 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 12:53 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 12:47 PM
RNS
Total Voting Rights
22 Jan 2016 03:01 PM
RNS
Director/PDMR Shareholding
21 Jan 2016 02:39 PM
RNS
Director/PDMR Shareholding
21 Jan 2016 02:36 PM
RNS
Director/PDMR Shareholding
18 Jan 2016 10:50 AM
RNS
Director/PDMR Shareholding
18 Jan 2016 10:47 AM
RNS
Director/PDMR Shareholding
15 Jan 2016 12:56 PM
RNS
Director/PDMR Shareholding
13 Jan 2016 04:09 PM
RNS
Director/PDMR Shareholding
08 Jan 2016 02:36 PM
RNS
Director/PDMR Shareholding
04 Jan 2016 04:00 PM
RNS
Director/PDMR Shareholding
04 Jan 2016 03:55 PM
RNS
Director/PDMR Shareholding
04 Jan 2016 02:28 PM
RNS
Total Voting Rights - Replacement
04 Jan 2016 10:56 AM
RNS
Total Voting Rights
23 Dec 2015 05:00 PM
RNS
Directorate Change
21 Dec 2015 11:30 AM
RNS
Completion of divestment of rights to ofatumumab
18 Dec 2015 11:55 AM
RNS
Director/PDMR Shareholding
18 Dec 2015 07:03 AM
RNS
ViiV Healthcare to acquire BMS R&D HIV assets
16 Dec 2015 01:59 PM
RNS
Positive results from sirukumab phIII programme
10 Dec 2015 04:15 PM
RNS
Director/PDMR Shareholding
10 Dec 2015 11:51 AM
RNS
Board Committee changes
02 Dec 2015 04:38 PM
RNS
Nucala European Marketing Authorisation Received
01 Dec 2015 03:21 PM
RNS
Director/PDMR Shareholding
01 Dec 2015 01:09 PM
RNS
Total Voting Rights
13 Nov 2015 02:14 PM
RNS
Director/PDMR Shareholding
12 Nov 2015 03:41 PM
RNS
Blocklisting Interim Review
11 Nov 2015 03:10 PM
RNS
Director/PDMR Shareholding
05 Nov 2015 07:00 AM
RNS
GSK's Nucala® receives approval from US FDA

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings